User profiles for K P Patel

Kaushik P. Patel

Professor of Physiology, UNMC
Verified email at unmc.edu
Cited by 11828

[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms

…, Y Natkunam, R Nejati, G Ott, E Padron, KP Patel… - leukemia, 2022 - nature.com
The upcoming 5th edition of the World Health Organization (WHO) Classification of
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in …

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19

KP Patel, PA Patel, RR Vunnam, AT Hewlett… - Journal of Clinical …, 2020 - Elsevier
There is an increasing number of confirmed cases and deaths caused by the Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) contributing to the Coronavirus disease …

The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients

KP Patel, TW O'Brien, SH Subramony, J Shuster… - Molecular genetics and …, 2012 - Elsevier
CONTEXT: Pyruvate dehydrogenase complex (PDC) deficiency is a genetic mitochondrial
disorder commonly associated with lactic acidosis, progressive neurological and …

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion

…, JR Giles, S McDonald, S Manne, SF Ngiow, KP Patel… - Nature, 2019 - nature.com
Exhausted CD8 + T (T ex ) cells in chronic infections and cancer have limited effector
function, high co-expression of inhibitory receptors and extensive transcriptional changes …

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

…, SA Fleming, Q Zhang, H Ma, KP Patel… - Blood, The Journal …, 2020 - ashpublications.org
The BCL-2 inhibitor venetoclax combined with hypomethylating agents or low-dose
cytarabine represents an important new therapy for older or unfit patients with acute myeloid …

Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study

…, Z Alhamal, C Bueso-Ramos, JL Jorgensen, KP Patel… - Cancer discovery, 2019 - AACR
Azacitidine in combination with nivolumab appeared to be a safe and effective therapy in
patients with AML who were salvage 1, prior hypomethylator-naïve, or had increased …

Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis

C Nitsche, PR Scully, KP Patel… - Journal of the American …, 2021 - jacc.org
Background Older patients with severe aortic stenosis (AS) are increasingly identified as
having cardiac amyloidosis (CA). It is unknown whether concomitant AS-CA has worse …

Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML

…, T Kadia, M Routbort, KP Patel… - American journal of …, 2015 - Wiley Online Library
The pathophysiology of IDH mutations in tumorigenesis is increasingly described, yet the
prognostic significance of IDH1 and IDH2 mutations in AML remains controversial. The primary …

[HTML][HTML] Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes

RR Singh, KP Patel, MJ Routbort, NG Reddy… - The Journal of molecular …, 2013 - Elsevier
Transfer of next-generation sequencing technology to a Clinical Laboratory Improvement
Amendments–certified laboratory requires vigorous validation. Herein, we validated a next-…

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

…, L Malcovati, AM Vannucchi, KP Patel… - Blood, The Journal …, 2022 - ashpublications.org
Myeloid neoplasms and acute leukemias derive from the clonal expansion of hematopoietic
cells driven by somatic gene mutations. Although assessment of morphology plays a crucial …